Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy March 22, 2021
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology March 12, 2021
Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference March 8, 2021
Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference February 25, 2021
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine December 21, 2020